Coty announces redesigned website
Coty Inc. plans to launch a revamped Coty.com as the company’s flagship website, along with a new employee intranet dubbed "The House." The fragrance and beauty care company said the new Coty.
Coty Inc. plans to launch a revamped Coty.com as the company’s flagship website, along with a new employee intranet dubbed "The House." The fragrance and beauty care company said the new Coty.
Encore, Encore! Vanessa Williams Welcomes M&M’S® Crispy Back To Shelves Voice of M&M’S® Character Ms. Brown Gives Fans a First Taste of M&M’S® Crispy After 10 Years Share with LinkedIn (December 9, 2014) Vanessa Williams, the multi-talented entertainer and voice behind M&M’S(R) Brand spokescandy Ms.
Mirixa Corp. plans to establish integration with PioneerRx, a rapidly growing pharmacy system provider. The pharmacy-based patient care network said Tuesday that the integration is already being used in pharmacies across the country.
Nutritional supplement maker Natrol Inc. has closed its agreement to be acquired by Aurobindo Pharma USA Inc. (APUSA) for $132.5 million. Natrol said late Monday that APUSA, a subsidiary of India-based generic drug and active pharmaceutical ingredient maker Aurobindo Pharma Ltd.
Brownmed has acquired baby care manufacturer NüRoo Inc., whose products are designed to foster the bond between mother and baby. Financial terms of the acquisition weren’t disclosed.
Moberg Pharma AB has rolled out Kerasal Nail Fungal Nail Repair, an extension of its Kerasal Nail product line. Moberg said CVS/pharmacy will be the first national drug chain to sell Kerasal Nail Fungal Nail Repair. Plans call for the product to launch in about 5,500 CVS drug stores in January.
Nozoil® Nasal Spray Product Availability Expands and Samples Offered to Consumers While product availability for Nozoil® Nasal Spray grows, consumers have the opportunity to try before they buy through the McKeon Products free sample giveaway program.
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New
Merck & Co. said Monday it will acquire Cubist Pharmaceuticals Inc. for $8.4 billion. The transaction will include $1.1 billion in net debt (based on projected cash balances) and other considerations for a total transaction value of about $9.5 billion.
GlaxoSmithKline PLC (GSK) has reversed a plan to possibly sell some of its established drugs in order to focus on fast-growing medications.
First Quality Tissue, a manufacturer of private-label and branded paper towels and tissue, is moving forward with several capacity expansion projects.
Galderma Laboratories’ Cetaphil skin care brand has made a foray in the baby product arena with the launch of Cetaphil Baby. Making its debut this week, the line includes five products: Cetaphil Baby Diaper Cream, Wash and Shampoo, Ultra Moisturizing Wash, Daily Lotion and Moisturizing Oil.
Avanir Pharmaceuticals Inc. has entered into an agreement to be acquired by Otsuka Pharmaceutical Co. Ltd. in a deal valued at $3.5 billion.
Actavis plc has released guanfacine hydrochloride tablets as part of a settlement agreement with Shire plc. Actavis said Monday that its product is a generic version of Shire’s Intuniv tablets, a medication for attention deficit hyperactivity disorder (ADHD).
Teva Pharmaceutical Industries Ltd. has launched amlodipine/valsartan/hydrochlorothiazide tablets, a hypertension medication, in the United States. Teva said Monday that its product is a generic equivalent of Exforge HCT tablets from Novartis.